Case Studiesadvanced12 min · 8 steps
Regulatory Compliance Automation
Pre-screen pharma marketing against FDA rules claim by claim, with citations, recall-first thresholds and a full audit trail.
legal review14days
heavy workerrordatarequestresponsesignal
metrics are illustrativeProblemStep 1 of 8
Two weeks of legal review per asset
A pharmaceutical company must keep every marketing asset within FDA regulations. Legal review takes 2 weeks per asset; the goal is AI pre-screening that cuts it to 2 days, at 500 assets a month.
The bar is high: cite the specific regulation section, never miss a violation (false negatives are unacceptable), keep false positives under 20%, and leave an audit trail for regulatory inspection.
InsightThe errors are asymmetric: a missed violation is catastrophic, an extra flag only costs a lawyer some time.
Lesson 12 of 20 in Case Studies